Family · Pharmaceutical analytical standards
Levocetirizine
A second-generation antihistamine for allergic rhinitis and chronic urticaria: it is the active enantiomer of cetirizine. Launched in 2001 and marketed across much of Europe, it was approved in the United States in 2007. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Cetirizine is a mixture of two mirror-image forms of the same molecule: all the antihistamine activity comes from levocetirizine, while the other half is practically inactive.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
